Your browser doesn't support javascript.
loading
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Miyazaki, Kana; Suzuki, Ritsuro; Oguchi, Masahiko; Taguchi, Senzo; Amaki, Jun; Maeda, Takeshi; Kubota, Nobuko; Maruyama, Dai; Terui, Yasuhito; Sekiguchi, Nodoka; Takizawa, Jun; Tsukamoto, Hiroyuki; Murayama, Tohru; Ando, Toshihiko; Matsuoka, Hiroshi; Hasegawa, Masatoshi; Wada, Hideho; Sakai, Rika; Kameoka, Yoshihiro; Tsukamoto, Norifumi; Choi, Ilseung; Masaki, Yasufumi; Shimada, Kazuyuki; Fukuhara, Noriko; Utsumi, Takahiko; Uoshima, Nobuhiko; Kagami, Yoshitoyo; Asano, Naoko; Ejima, Yasuo; Katayama, Naoyuki; Yamaguchi, Motoko.
Afiliación
  • Miyazaki K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Suzuki R; Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan.
  • Oguchi M; Department of Radiation Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Taguchi S; Department of Radiation Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Amaki J; Division of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Maeda T; Department of Haematology and Oncology, Kurashiki Center Hospital, Kurashiki, Japan.
  • Kubota N; Division of Hematology, Saitama Cancer Center, Ina, Japan.
  • Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Terui Y; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Sekiguchi N; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takizawa J; Department of Hematology, Saitama Medical University, Moroyama, Japan.
  • Tsukamoto H; Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto, Japan.
  • Murayama T; Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
  • Ando T; Division of Hematology, Showa University School of Medicine, Tokyo, Japan.
  • Matsuoka H; Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
  • Hasegawa M; Division of Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan.
  • Wada H; Medical Oncology/Hematology, Kobe University, Kobe, Japan.
  • Sakai R; Department of Radiation Oncology, Nara Medical University, Kashihara, Japan.
  • Kameoka Y; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
  • Tsukamoto N; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Choi I; Department of Hematology, Akita University, Akita, Japan.
  • Masaki Y; Oncology Center, Gunma University Hospital, Maebashi, Japan.
  • Shimada K; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Fukuhara N; Division of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.
  • Utsumi T; Department of Hematology and Oncology, Nagoya University School of Medicine, Nagoya, Japan.
  • Uoshima N; Department of Hematology & Rheumatology, Tohoku University School of Medicine, Sendai, Japan.
  • Kagami Y; Department of Hematology, Shiga General Hospital, Moriyama, Japan.
  • Asano N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Ejima Y; Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
  • Katayama N; Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan.
  • Yamaguchi M; Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan.
Hematol Oncol ; 40(4): 667-677, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35142384

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Extranodal de Células NK-T Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón